Boston Scientific (NYSE:BSX) today announced a definitive agreement to acquire cardiovascular disease treatment device maker ...
Boston Scientific’s $374/share Penumbra deal boosts mechanical thrombectomy exposure and growth. Click here to learn more ...
Inari Medical Inc. was just a 25-person startup when Drew Hykes arrived in 2017 as chief commercial officer.What most ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback